BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ling Tan JS, Roberts CJ, Billa N. Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B. Pharmaceutical Development and Technology 2019;24:504-12. [DOI: 10.1080/10837450.2018.1515225] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Mathews PD, Mertins O, Angelov B, Angelova A. Cubosomal lipid nanoassemblies with pH-sensitive shells created by biopolymer complexes: A synchrotron SAXS study. J Colloid Interface Sci 2022;607:440-50. [PMID: 34509118 DOI: 10.1016/j.jcis.2021.08.187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Noorulla K, Yasir M, Muzaffar F, S R, Ghoneim MM, Almurshedi AS, Tura AJ, Alshehri S, Gebissa T, Mekit S, Ahmed MM, Zafar A. Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation. Journal of Drug Delivery Science and Technology 2022;67:102939. [DOI: 10.1016/j.jddst.2021.102939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zou Q, Xiong SW, Jiang MY, Chen LY, Zheng K, Fu PG, Gai JG. Highly thermally conductive and eco-friendly OH-h-BN/chitosan nanocomposites by constructing a honeycomb thermal network. Carbohydr Polym 2021;266:118127. [PMID: 34044943 DOI: 10.1016/j.carbpol.2021.118127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bhaskaran NA, Jitta SR, Salwa, Cheruku S, Kumar N, Kumar L. Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: Preparation, in-vitro and in-vivo evaluations. Int J Biol Macromol 2022;211:301-15. [PMID: 35568152 DOI: 10.1016/j.ijbiomac.2022.05.060] [Reference Citation Analysis]
5 Hnik P, Wasan EK, Wasan KM. Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration. Antimicrob Agents Chemother 2020;64:e01450-20. [PMID: 32690643 DOI: 10.1128/AAC.01450-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Eid RK, Ashour DS, Essa EA, El Maghraby GM, Arafa MF. Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis. Carbohydr Polym 2020;232:115826. [PMID: 31952620 DOI: 10.1016/j.carbpol.2019.115826] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
7 Sumaila M, Marimuthu T, Kumar P, Choonara YE. Lipopolysaccharide Nanosystems for the Enhancement of Oral Bioavailability. AAPS PharmSciTech 2021;22:242. [PMID: 34595578 DOI: 10.1208/s12249-021-02124-5] [Reference Citation Analysis]
8 Dasineh S, Akbarian M, Ebrahimi HA, Behbudi G. Tacrolimus-loaded chitosan-coated nanostructured lipid carriers: preparation, optimization and physicochemical characterization. Appl Nanosci 2021;11:1169-81. [DOI: 10.1007/s13204-021-01744-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wasan KM, Wasan EK, Hnik P. Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle Dogs. Antimicrob Agents Chemother 2020;64:e01111-20. [PMID: 32816728 DOI: 10.1128/AAC.01111-20] [Reference Citation Analysis]
10 Xu Y, Fourniols T, Labrak Y, Préat V, Beloqui A, des Rieux A. Surface Modification of Lipid-Based Nanoparticles. ACS Nano 2022. [PMID: 35446546 DOI: 10.1021/acsnano.2c02347] [Reference Citation Analysis]
11 Younus I, Khan SJ, Maqbool S, Begum Z. Anti-fungal therapy via incorporation of nanostructures: A systematic review for new dimensions. Phys Scr 2022;97:012001. [DOI: 10.1088/1402-4896/ac445d] [Reference Citation Analysis]
12 Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology 2022;20:362. [PMID: 35933341 DOI: 10.1186/s12951-022-01539-x] [Reference Citation Analysis]
13 Subramaniam B, Siddik ZH, Nagoor NH. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-04848-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
14 Kaur K, Kumar P, Kush P. Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection. Biomed Pharmacother 2020;128:110297. [PMID: 32480227 DOI: 10.1016/j.biopha.2020.110297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mahmoudian M, Maleki Dizaj S, Salatin S, Löbenberg R, Saadat M, Islambulchilar Z, Valizadeh H, Zakeri-Milani P. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate. Expert Opin Drug Deliv 2021;18:1707-22. [PMID: 34553650 DOI: 10.1080/17425247.2021.1982891] [Reference Citation Analysis]
16 Jafari M, Abolmaali SS, Tamaddon AM, Zomorodian K, Sarkari BS. Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine (Lond) 2021;16:857-77. [PMID: 33890492 DOI: 10.2217/nnm-2020-0482] [Reference Citation Analysis]
17 Kumar Singh P, Gorain B, Choudhury H, Kumar Singh S, Whadwa P, Shilpa, Sahu S, Gulati M, Kesharwani P. Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis. Materials Science and Engineering: B 2020;258:114571. [DOI: 10.1016/j.mseb.2020.114571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Tirumalesh C, Suram D, Dudhipala N, Banala N. Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application. Pharm Nanotechnol 2020;8:148-60. [PMID: 32096755 DOI: 10.2174/2211738508666200225113359] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
19 Elad D. Therapy of Non-Dermatophytic Mycoses in Animals. J Fungi (Basel) 2018;4:E120. [PMID: 30380772 DOI: 10.3390/jof4040120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Dawoud M, Abdou R. Ion exchange column technique as a novel method for evaluating the release of docetaxel from different lipid nanoparticles. Drug Deliv Transl Res 2021. [PMID: 33768474 DOI: 10.1007/s13346-021-00937-2] [Reference Citation Analysis]
21 Tan JSL, Roberts C, Billa N. Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats. Journal of Biomaterials Science, Polymer Edition 2020;31:141-54. [DOI: 10.1080/09205063.2019.1680926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Frank L, Onzi G, Morawski A, Pohlmann A, Guterres S, Contri R. Chitosan as a coating material for nanoparticles intended for biomedical applications. Reactive and Functional Polymers 2020;147:104459. [DOI: 10.1016/j.reactfunctpolym.2019.104459] [Cited by in Crossref: 47] [Cited by in F6Publishing: 12] [Article Influence: 23.5] [Reference Citation Analysis]
23 Kang NW, Yoon SY, Kim S, Yu NY, Park JH, Lee JY, Cho HJ, Kim DD. Subcutaneously Injectable Hyaluronic Acid Hydrogel for Sustained Release of Donepezil with Reduced Initial Burst Release: Effect of Hybridization of Microstructured Lipid Carriers and Albumin. Pharmaceutics 2021;13:864. [PMID: 34208289 DOI: 10.3390/pharmaceutics13060864] [Reference Citation Analysis]
24 Tan SLJ, Billa N. Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles. Pharmaceutics 2021;13:1817. [PMID: 34834232 DOI: 10.3390/pharmaceutics13111817] [Reference Citation Analysis]
25 Gilani SJ, Bin-jumah M, Rizwanullah M, Imam SS, Imtiyaz K, Alshehri S, Rizvi MMA. Chitosan Coated Luteolin Nanostructured Lipid Carriers: Optimization, In Vitro-Ex Vivo Assessments and Cytotoxicity Study in Breast Cancer Cells. Coatings 2021;11:158. [DOI: 10.3390/coatings11020158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
26 Faustino C, Pinheiro L. Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics 2020;12:E29. [PMID: 31906268 DOI: 10.3390/pharmaceutics12010029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
27 Wasan KM. Development of an Oral Amphotericin B Formulation as an Alternative Approach to Parenteral Amphotericin B Administration in the Treatment of Blood-Borne Fungal Infections. Curr Pharm Des 2020;26:1521-3. [PMID: 32160842 DOI: 10.2174/1381612826666200311130812] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Ling JTS, Roberts CJ, Billa N. Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC). AAPS PharmSciTech 2019;20:136. [PMID: 30838459 DOI: 10.1208/s12249-019-1346-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
29 Nimtrakul P, Williams DB, Tiyaboonchai W, Prestidge CA. Copolymeric Micelles Overcome the Oral Delivery Challenges of Amphotericin B. Pharmaceuticals (Basel) 2020;13:E121. [PMID: 32545189 DOI: 10.3390/ph13060121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Shoueir KR, El-Desouky N, Rashad MM, Ahmed MK, Janowska I, El-Kemary M. Chitosan based-nanoparticles and nanocapsules: Overview, physicochemical features, applications of a nanofibrous scaffold, and bioprinting. Int J Biol Macromol 2021;167:1176-97. [PMID: 33197477 DOI: 10.1016/j.ijbiomac.2020.11.072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
31 Cuddihy G, Wasan EK, Di Y, Wasan KM. The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized? Pharmaceutics 2019;11:E99. [PMID: 30813569 DOI: 10.3390/pharmaceutics11030099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
32 Vercelli C, Peano A, Piovano G, Corona A, Gambino G, Re G. Diagnostic and therapeutic management of Cryptococcosis in a kitten with practical considerations to veterinary pediatric therapeutic approach. Med Mycol Case Rep 2021;32:61-3. [PMID: 33912382 DOI: 10.1016/j.mmcr.2021.04.001] [Reference Citation Analysis]